Skip to main content

Advertisement

SpringerLink
Log in

Botulinum toxin and rehabilitation treatment in inclusion body myositis for severe oropharyngeal dysphagia

  • Letter to the Editor
  • Published:
Neurological Sciences Aims and scope Submit manuscript

An Erratum to this article was published on 26 November 2016

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Paltiel AD, Ingvarsson E, Lee DK, Leff RL, Nowak RJ, Petschke KD, Richards-Shubik S, Zhou A, Shubik M, O’Connor KC (2015) Demographic and clinical features of inclusion body myositis in North America. Muscle Nerve 52(4):527–533

    Article  PubMed  PubMed Central  Google Scholar 

  2. Cox FM, Verschuuren JJ, Verbist BM, Niks EH, Wintzen AR, Badrising UA (2009) Detecting dysphagia in inclusion body myositis. J Neurol 256(12):2009–2013

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Murata KY, Kouda K, Tajima F, Kondo T (2012) A dysphagia study in patients with sporadic inclusion body myositis (s-IBM). Neurol Sci 33(4):765–770

    Article  PubMed  Google Scholar 

  4. Masiero S, Briani C, Marchese-Ragona R, Giacometti P, Costantini M, Zaninotto G (2006) Successful treatment of long-standing post-stroke dysphagia with botulinum toxin and rehabilitation. J Rehabil Med 38(3):201–203

    Article  PubMed  Google Scholar 

  5. Liu LW, Tarnopolsky M, Armstrong D (2004) Injection of botulinum toxin A to the upper esophageal sphincter for oropharyngeal dysphagia in two patients with inclusion body myositis. Can J Gastroenterol 18(6):397–399

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neuroscience, University of Padova, Via Giustiani, 3, Padua, Italy

    Chiara Di Pede MD, Stefano Masiero MD, Valentina Bonsangue MD & Alessandra Del Felice MD, PhD

  2. Department of Ear-Nose-Throat and Head-Neck Surgery, University of Padova, Padua, Italy

    Rosario Marchese Ragona MD

Authors
  1. Chiara Di Pede MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Stefano Masiero MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Valentina Bonsangue MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rosario Marchese Ragona MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alessandra Del Felice MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alessandra Del Felice MD, PhD.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical standard

Patient’s anonymity was protected in this case report.

Additional information

An erratum to this article is available at http://dx.doi.org/10.1007/s10072-016-2774-8.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Di Pede, C., Masiero, S., Bonsangue, V. et al. Botulinum toxin and rehabilitation treatment in inclusion body myositis for severe oropharyngeal dysphagia. Neurol Sci 37, 1743–1745 (2016). https://doi.org/10.1007/s10072-016-2586-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-016-2586-x

Keywords

Search

Navigation